AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Influence of Lung Ultrasonography on the Prognosis and Postoperative Outcomes in Cardiac Surgical Patients

RecruitingNAAges 18 Years - anyAllSaint Petersburg State University, Russia
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

The goal of this interventional is to assess advantages of the ultrasound examination of the lungs in the early postoperative period in cardiac surgical patients after heart surgeries requiring cardiopulmonary bypass. Evaluation of pulmonary complications and outcomes during mid-term follow-up, as well as comparison of ultrasound examination and traditional roentgenologic methods (X-ray examination and CT of the chest) will be performed. The main question\[s\] it aims to answer are: * Is ultrasound examination of the lungs a more specific and sensitive method in identification of early postoperative pulmonary complications after on-pump cardiac surgical procedures, in comparison with traditional X-ray methods. * Does early identification of interstitial pulmonary edema (based on number of visualised B-lines in the early postoperative period), influences mid-term outcomes in this cohort

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * open heart surgery with cardiopulmonary bypass (CPB) between 15 December 2023 and 15 December 2024 * signed informed consent for participation in the study Exclusion Criteria: * reoperations on the open heart with CPB * surgical procedures on lungs and lung cancer in the anamnesis * chronic obstructive pulmonary disease, stage III * chronic kidney disease, stages 4 and 5 * patients with low Risk Score profile by the Society of Thoracic Surgeons
๐Ÿ’Š

What it tests

  • Ultrasound examination of the lungs
๐Ÿ“

Where

1 site
Saint Petersburg State University Clinic
Saint Petersburg, Russia
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy